Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Owl Technology Income Corp (OTIC) is a non-traded business development company (BDC) that provides private credit and financing solutions to technology-related companies. Managed by an affiliate of Blue Owl Capital, the fund primarily originates and invests in senior secured loans to high-growth software, data, and technology-enabled businesses. Its investment strategy targets companies with durable business models and strong recurring revenue streams, including those in the healthcare technology and bioinformatics sectors. While it is a financial entity rather than a biotechnology firm, it serves as a significant capital provider for the broader technology ecosystem. The fund aims to generate current income and capital appreciation for its investors through a diversified portfolio of private debt.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Owl Technology Income.